Biotherapeutics

China’s Duality Biotherapeutics shares rise 130% in Hong Kong debut
[SYDNEY] Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday (Apr 15), after the Chinese firm raised US$213 million in an initial public offering (IPO)...